Tirzepatide treatment was administered at three final doses (5, 10, 15 mg per week), with treatment initiated at 2.5 mg and the dose escalated every 4 weeks
Chronic central ghrelin infusion reduces blood pressure and heart rate despite increasing appetite and promoting weight gain in normotensive and hypertensive rats
Evaluate response and further increase the total weekly dose in 2.5/mg increments, as needed
Effect of Semaglutide on Gut Microbiota As a dynamic interface between diet, host metabolism, and drug response, the intestinal microbiota represents a critical, yet often overlooked, factor in the personalisation of obesity treatment
Throughout the discussion, Norton offers a nuanced perspective grounded in a meticulous analysis of available research data and trends across multiple high-quality studies